When:
Tuesday, May 22, 2018 8:00a -
Thursday, May 24, 2018 4:00p

Where:
Westin Boston Waterfront
United States
Boston, MA 02210

EventScheduled OfflineEventAttendanceMode

Admission:
$2799

Categories:
Business

Event website:
http://go.evvnt.com/197029-3?pid=5248

This is your first and only opportunity to listen to the most advanced clinical case studies from Nektar Therapeutics and Amgen which explore the use of IL-2 to enhance the expansion and activation of the Treg cells. Delve deeper with expert insights from Roche and ILTOO Pharma to understand how IL-2 at low doses could selectively stimulate Treg cells.


Identify yourself as a leader in this community and join the discussion exploring the challenges in translating a proof of concept in autoimmune therapies from animal models to clinic. This meeting will provide the platform for conversations to be had to accelerate the clinical translation of Treg directed therapies.


URLs:
Booking https://go.evvnt.com/197029-0?pid=5248
Brochure https://go.evvnt.com/197029-1?pid=5248
Inquiries https://go.evvnt.com/197029-2?pid=5248


Prices:
Conference Only (Earlybird ends Feb 23): USD 1999
Conference Only (Earlybird ends Mar 23): USD 2199
Conference Only (Earlybird ends Apr 20): USD 2399
Conference Only: USD 2799
Conference Academic Only (Earlybird ends Feb 23): USD 1399
Conference Academic Only (Earlybird ends Mar 23): USD 1599
Conference Academic Only (Earlybird ends Apr 20): USD 1799
Conference Academic Only: USD 1999
Workshop Only: USD 499


Speakers: Chris Haqq, Kevin Gorski, Nadia Tchao, David Wraith, Andrew Scharenberg, Simrit Parmar, Robert Plenge, Stephen Miller, Todd Brusko, Jérémie Mariau, Laurence Turka, Jason Fontenot, Leonard Dragone, Jonathan Zalevsky, Aaron Winkler, David Klatzmann, Jonathan Esensten, Leslie Kean, Annalisa D’Andrea, Rosa Bacchetta, Qizhi Tang, Dennis Kasper, Stephane Boissel, Pierre Heimendinger, Rose Szabady, David Hafler


Category: Conferences | Science, Health and Medicine | Oncology

Share this event

Add to:

Reddit
05/22/2018 08:00:00 05/24/2018 16:00:00 America/New_York Treg Directed Therapy for Autoimmune Disorders Summit 2018 This is your first and only opportunity to listen to the most advanced clinical case studies from Nektar Therapeutics and Amgen which explore the use of IL-2 to enhance the expansion and activation...

https://www.thebostoncalendar.com/events/treg-directed-therapy-for-autoimmune-disorders-summit-2018
Westin Boston Waterfront, Boston, MA 02210 false MM/DD/YYYY

Sponsored events